NA Proactive news snapshot: RedHill Biopharma, Phyto Extractions, Kainantu Resources, BioSig Technologies UPDATE …

RedHill Biopharma Ltd (NASDAQ:RDHL) announced that the global Phase 2/3 study with orally-administered opaganib (Yeliva®, ABC294640) in patients hospitalized with severe COVID-19 pneumonia has received a unanimous recommendation to continue, following a fourth independent Data Safety Monitoring Board (DSMB) review. The company said the DSMB's recommendation is based on an analysis of unblinded safety data from the first 255 patients treated for 14 days, extending the total opaganib safety database to about 380 patients. RedHill said the global Phase 2/3 randomized, double-blind, parallel-arm, placebo-controlled study of opaganib in patients with severe COVID-19 pneumonia requiring hospitalization and treatment with supplemental oxygen, is over 75% enrolled, with completion of enrollment expected in the coming weeks. Phyto Extractions Inc (CSE:XTRX)(FRA:D2EP), formerly Adastra Labs Holdings Ltd, has announced the launch of three new Shatter Products, adding to its product line in the burgeoning cannabis extracts market. A favourite among Cannabis enthusiasts, Phyto Extractions shatter product line launches with three of the most popular cannabis strain extracts on the market through its one gram offerings; Pink Kush, Blueberry Gorilla and Death Bubba. The Shatter products will be launched in British Columbia (BC), Alberta, Saskatchewan, Manitoba, and Ontario with the rest of Canada to follow soon thereafter, in addition to new shatter products that are in development. Kainantu Resources Ltd (CVE:KRL) has told investors that it believes its KRL South project in Papua New Guinea could host multiple epithermal, skarn and porphyry systems. The Vancouver-based company said that ongoing work at KRL South supports the idea of a “high-quality” exploration target close to existing mines in the wider Kainantu district. Asia-focused Kainantu is nearing completion of a focused, multi-element soil sampling program that has collected nearly 2,000 samples so far, over 54 line kilometres sampled. BioSig Technologies Inc (NASDAQ:BSGM) said it has accepted an invitation to join the Alliance for Artificial Intelligence in Healthcare (AAIH). The AAIH invite came after the company was awarded US patents for its artificial intelligence-based platform. BioSig noted that the AAIH is the global advocacy organization for the advancement and use of AI in healthcare to improve patients’ lives and create more efficient, sustainable, and accessible healthcare systems. Vuzix Corporation (NASDAQ:VUZI) has announced an upcoming online panel discussion featuring Medtronic, a global leader in medical technology solutions, and TeamViewer, a leading provider of remote access software, to discuss key takeaways for a successful deployment of augmented reality for enterprise customers. Given the continued disruption to global operations due to the coronavirus pandemic, organizations are adopting Smart Glasses solutions to adapt the way they do business, with Vuzix M400 smart glasses being used to assist in medical applications. The panel event will address key scaling challenges common across industries, particularly how Medtronic has applied innovation to better support their customers and enable growth through augmented clinical case coverage. Alternus Energy Group PLC (NOTC:ALT) is set to see a nearly tenfold increase in its power capacity by the end of 2023. The European independent power producer told investors that it has agreed terms to acquire over 1.2 GWp of additional solar PV projects, set to be acquired this year. If all projects reach commercial operation, the total asset base would increase by over ten times from today’s levels – and generate around €85 million in annual recurring revenues, according to Alternus.  CytoDyn Inc (OTCQB:CYDY), a biotechnology company developing its flagship drug Vyrologix (leronlimab-PRO 140) for multiple indications, revealed that its coronavirus (COVID-19) long-haulers study (CD15) is now fully enrolled. The Vancouver, Washington-based biotechnology company noted that enrollment was “faster than expected” because of the high number of patients wanting to participate, which now includes 56 patients in the trial. This is a multicenter Phase 2, two-arm, randomized, double-blind, placebo-controlled study to evaluate the safety and effectiveness of Vyrologix in the treatment of patients with prolonged COVID-19 symptoms, a condition now known as Post-Acute COVID Syndrome (PACS). Aurania Resources Ltd (CVE:ARU) (OTCMKTS:AUIAF) (FRA:20Q) said it has been encouraged by finding black "pyrobitumen" when drilling its Kuri-Yawi target at the flagship Lost Cities - Cutucu project in Ecuador. The diamond drill hole has encountered epithermal-type veining in brecciated basalt with "significant" amounts of black "pyrobitumen" - a pseudo-mineral composed of carbon and derived from hydrocarbon. "I consider this discovery of pyrobitumen to be potentially of high significance," said Aurania's CEO, Dr Keith Barron in a statement. Imagine AR Inc (CSE:IP) (OTCQB:IPNFF), an augmented reality company that enables sports teams, businesses and enterprises to create AR mobile campaigns, announced that its technology was chosen by two motorsports organizations during the second day of the Hype Sports Innovation Accelerator draft on April 8. The virtual event saw sports teams and organizations from around the world “draft” partnerships with start-up technology companies, including ImagineAR. On day two, the company was chosen by Automotive Industries magazine and AirSpeeder motorsport series. Over both days, the company has been selected by a total of 15 organizations and teams. PsyBio Therapeutics Corp (CVE:PSYB) announced it has retained investor relations firm Kanan Corbin Schupak & Aronow Inc (KCSA Strategic Communications) to raise its profile in the financial community. “PsyBio has selected KCSA to enhance its visibility and profile in the financial community, as the company continues to execute on its strategies,” it said in a statement. Toronto-based PsyBio develops novel formulations of psychoactive medications produced by genetically modified bacteria for the treatment of mental health and other disorders. American Manganese Inc (CVE:AMY) (OTCQB:AMYZF) (FRA:2AM) said it has improved its manganese processing flowsheet following the recent research and development on the Wenden Stockpile reclamation and advanced material processing bench-scale project, which was funded by the US Defense Logistics Agency (DLA). The company said it expects the flowsheet enhancements to further improve process efficiencies and reduce capital costs of a potential future commercial operation, as recent metallurgical bench-scale studies that focused on solid-liquid separation demonstrated that the original flowsheet can be optimized. KWESST Micro Systems Inc (CVE:KWE) (OTCQB:KWEMF) and lead agent PI Financial Corp, have agreed to upsize the company’s previously announced brokered private placement to raise total gross proceeds of $4 million, up from C$2.5 million. The company now intends to issue 3.2 million units at a price of C$1.25 per unit. The 3.2 million units have been allocated to subscribers and the offering is scheduled to close on or about April 29, 2021. Given the upsize, the parties have agreed to remove the over-allotment option. American Battery Metals Corporation (OTCQB:ABML), soon to be called American Battery Technology Company (ABTC), announced that its COO Menka Sethi will speak at the US Energy Storage Association's (ESA) upcoming Virtual Energy Storage Conference & Expo. The two-day conference to be held April 21-22, will focus on "The Storage Decade" and include discussions around the growing need to decarbonize the economy, the company said.  Sethi will join other energy storage industry leaders in speaking at the event.  Sethi plans to discuss the company's closed-loop lithium-ion battery recycling platform that ABTC says has potential to benefit the energy storage industry. Hillcrest Petroleum Ltd (CSE:HEAT) (OTCMKTS:HLRTF) (FRA:7HI.F) has announced its rebranding as Hillcrest Energy Technologies Ltd, choosing an identity more representative of its dedication to transitioning from fossil fuel production to clean tech innovation and intellectual property (IP) development. Meanwhile, CEO Don Currie announced the appointment of industry veteran Kylie Dickson to the board of directors. “Hillcrest is committed to driving positive innovation on all fronts, and it is important that our brand refresh also carries this message,” Currie said. “Building shareholder value by owning, developing and optimizing clean Energy Technologies is an absolute priority, but the team is equally focused on creating a sustainable business environment that embraces important industry and societal shifts occurring around the world.” Revive Therapeutics Ltd. (CSE:RVV) (OTCMKTS:RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, has provided the dial-in information for its upcoming Annual and Special Meeting scheduled to be held at 11.00am Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign. In consideration of the coronavirus (COVID-19) pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the meeting via teleconference and will not be permitted to attend the meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders. Neo Lithium Corp (CVE:NLC) said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement announced March 16, 2021, which will see the issue of 860,870 common shares at a purchase price of $3.05 per common share with one placee. Water Tower Research has said its latest Fireside Chat Series will feature  Barrie Finnin, CEO, and Stuart Douglas, executive director of Amaro International on Monday, April 12 at 5.00pm EDT (2.00pm PDT). Amaero is a world-recognized technology leader in 3D printing for aerospace and defense. 3D printing is now the fastest-growing sector globally, with CAGRs of 60+% or 10x expected over the next five years according to an ARK white paper. Water Tower said the capital markets in this sector have also been strong, with some recent SPACs and rumors of more listings to come in the near future. Interested investors can register for the event using the following link: https://globalmeet.webcasts.com/starthere.jsp?ei=1451153&tp_key=7c4cd882a5 EVmo, Inc. (OTCMKTS:YAYO), a leading provider of vehicles to the rideshare and delivery gig economy industry, has announced that an interview with CEO Stephen Sanchez will air on The RedChip Money Report on the Bloomberg Network in the US on Saturday, April 10 at 7.00pm local time across the United States.  To view the interview segment, investors can use the following link: https://youtu.be/7ng5M5yyykk WeedMD Inc. (CVE:WMD) (OTCQX:WDDMF) (FRA:4WE) has said it will file its financial statements and management’s discussion and analysis for the fourth quarter and fiscal year ended December 31, 2020, after the market close on Thursday, April 29, 2021. The company will host a conference call to discuss the results, and provide an operational update on Friday, April 30, 2021, at 10.00am Eastern Time. The call will be hosted by CEO and Executive Chairman George Scorsis and CFO Lincoln Greenidge. Management will be available for questions following opening remarks. Dial-in details: Canada/USA: 1-800-319-4610. International Toll: 1-604-638-5340. Replay Dial-in available after 12.00pm Eastern Time until May 30, 2021: Canada/USA: 1-800-319-6413. International Toll: 1-604-638-9010; Replay Access Code: 6629. WeedMD also confirmed that effective March 30, 2021, the TSX Venture Exchange listed 19,046,875 of its common share purchase warrants for trading under the symbol “WMD.WT.A” in connection with the company’s previously announced bought deal short-form prospectus offering of units. Plurilock Security Inc. (CVE:PLUR) (OTCQB:PLCKF), a leading provider of invisible and continuous authentication technologies for enterprises, has announced that Ian L. Paterson, its CEO, will be a featured guest on Michael Campbell's MoneyTalks on Saturday, April 10, 2021, at 10.00am PST. The company said Paterson will be hosting a live webinar immediately following the broadcast at 10.15am PST with more in-depth analysis of the cybersecurity market and Plurilock's recent US acquisition of Aurora Systems Consulting, Inc. To sign up for the live investor webinar, investors can register at the following link: https://www.plurilock.com/moneytalks